Skip to main content
Log in

Lack of hormonal changes in postmenopausal women of equal weight with and without osteoporosis, including relation to time of menopause

  • Originals
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Summary

The hormonal variations in postmenopausal osteoporosis are not precisely defined. The duration of the menopause and other factors, such as the weight of the patients, may be of significance. Having a basic criterion of uniformi ty in weight, sixty postmenopausal women were studied in regard to the following aspects: urinary hydroxyproline, estrone, estradiol, parathyroid hormone, thyrox ine, triiodothyronine, thyroid stimulating hormone, cortisol and metacarpal cortical area/total area. They were divided into: Group A: 15 patients with osteoporosis and five years since menopause; Group B: 15 patients without osteoporosis (age matched with group A); Group C: 15 patients with osteoporosis and more than ten years since menopause; and Group D: 15 patients without osteoporosis (age matched with Group C). In the group with postmenopausal osteoporosis (A and C) there is a significant increase in urinary hydroxyproline/creatinine and a significant decrease of the cortical area/total area when we compared them with age-matched groups. The hormonal values do not vary significantly among the four groups. Ours results indicate an increase of bone resorption as a cause of postmenopausal osteoporosis. The hormonal variations, if any, cannot be related to basal values.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Riggs, B.L. Hormonal factors in the pathogenesis of postmenopausal osteoporosis. In: Barzel US. Osteoporosis II. New York, Grune & Stratton, 1979, 111.

    Google Scholar 

  2. Avioli, L.V. The endoctrinology of involutional osteoporosis. In: Osteoporosis: Recent advances in pathogenesis and treatment. DeLuca H.F., Frost, H.M., Jee, W.S.S., Johnston, C., Parfitt, A.M. Baltimore, University Park Press, 1980, 343.

    Google Scholar 

  3. Johnston, C., Epstein, S. The endocrinology of osteoporosis. In: Endocrinology of calcium metabolism. Parson JA. New York, Raven Press, 1982, 467.

    Google Scholar 

  4. Albright, F., Reifenstein, E.C. Parathyroid glands and metabolic bone disease. Baltimore Williams and Wilkins, 1948.

    Google Scholar 

  5. Taggart, H.M., Chesnut, C.H., Ivey, J.L., Baylink, D.J., Sisom, K., Huber, M.B., Roos, B.A. Deficient calcitonin response to calcium stimulation in postmenopausal osteoporosis? Lancet, 1982, 2, 475–477.

    Google Scholar 

  6. Rico, H., Del Rio, A., Vila, T., Patino, R., Carrera, F., Espinos D. The role of growth hormone in the pathogenesis of postmenopausal osteoporosis. Arch Intern Med, 1979, 139, 1263–1265.

    Google Scholar 

  7. Avioli, L.V., Baran, D.T., Whyte, M.P., Teiltebaum, S. The biochemical and skeletal heterogeneity of postmenopausal osteoporosis. In: Barzel US: Osteoporosis II. New York, Grune & Stratton. 1979, 49.

    Google Scholar 

  8. Meunier, P.J., Coupron, P., Edouard, C., Alexandre, C., Bressot, C., Lips, P., Boyce B.F. Bone histomorphometry in osteoporotic states. In: Barzel US. Osteoporosis II. New York, Grune & Stratton, 1979, 27.

    Google Scholar 

  9. Meema, H.E., Bunker, M.L., Meema, S. Loss of compact bone due to menopause. Obstet Gynecol, 1965, 26, 333–343.

    Google Scholar 

  10. Aitken, J.M., Hart, D.M., Anderson, J.B., Lindsay, R., Smith, D.A., Speirs, C.T. Osteoporosis after oöphorectomy for non-malignant disease in premenopausal women. Br J Med, 1973, 2, 325–328.

    Google Scholar 

  11. Horsman, A., Simpson, M., Kirby, D.A., Nordin, B.E.C. Non-linear bone loss in oophorectomized women. Br J Radiol, 1977, 50, 504–507.

    Google Scholar 

  12. Chakravarti, S., Collins, W.P., Forescat, J.D., Newton, J.R., Oram, D.H., Studd, J.W.W. Hormonal profiles after the menopause. Br Med J, 1976, 2, 78–786.

    Google Scholar 

  13. Saville, P.D., Nilsson, B.E.R. Height and weight in symptomatic postmenopausal osteoporosis. Clin Orthop, 1966, 45, 49–57.

    Google Scholar 

  14. Lindquist, C., Bengtsson, C., Hansson, T., Roos, B. Bone mineral content in relation to age and menopause in middle-aged women. Scand J Clin Lab Invest, 1981, 41, 215–223.

    Google Scholar 

  15. Davidson, S.J., Ross, R.K., Paganini-Hill, A., Hammond, G.D., Sliteri, P.K., Judd, H.L. Total and free estrogens and androgens in postmenopausal women with hip fratures. J Clin Endocrinol Metab, 1982, 54, 115–120.

    Google Scholar 

  16. Horsman, A., Simpson, B. The measurement of sequential changes in cortical bone geometry. Br J Radiol, 1975, 48, 471–476.

    Google Scholar 

  17. Rico Lenza, H., Del Rio Vàzquez, A., Lozano Tonkin, C., Cigüenza Gabriel, R., Espinos Perez. Paràmetros de masa òsea en la poblaciòn normal española. Rev Clin Esp, 1978, 148, 475–478.

    Google Scholar 

  18. Prockop, D.J., Udenfriend, S. A specific method for the analysis of hydroxyproline in tissue and urine. Anal Biochem, 1960, 1, 228–239.

    Google Scholar 

  19. Tausky, H.H. A microcolorometric determination of creatinine in urine by the Jaffe reaction. J Biol Chem, 1954, 208, 853–856.

    Google Scholar 

  20. Wu, C.H., Lundy, L.E. Radioimmunoassay of plasma estrogens. Steroids, 1971, 18, 91–111.

    Google Scholar 

  21. Dull, T.A., Henneman, P.H. Urinary hydroxyproline as an index of colagen turnover in bone. N Engl J Med, 1963, 268, 132–134.

    Google Scholar 

  22. Powles, T.J., Leese, C.L., Bondy, P.K. Hydroxyproline excretion in patients with breast cancer and response to treatment. Br Med J, 1975, 2, 164–166.

    Google Scholar 

  23. Nordin, B.E.C. Diagnostic procedures in disorders of calcium metabolism, Din Endocrinol, 1978, 8, 55–67.

    Google Scholar 

  24. Delmas, P.D., Stenner, D., Wahner, H.W., Mann, K.G., Riggs, B.L. Serum bone GLA protein increases with aging in normal women: Implications for age-related bone loss. Calcif Tissue Int, 1982, [Suppl], 34, S4.

    Google Scholar 

  25. Nordin, B.E.C., Aaron, J., Speed, R., Crilly, R.G., Bone formation and resorption as the determinants of trabecular bone volume in postmenopausal osteoporosis. Lancet, 1981, 8, 277–279.

    Google Scholar 

  26. Lafferty, F.W., Spencer, G.E., Perason, O.H. Effects of androgens, estrogens and high calcium intakes on bone formation and resorption in osteoporosis. Am J Med, 1964, 36, 515–528.

    Google Scholar 

  27. Harris, W.H., Heaney, R.P. Skeletal renewal and metabolic bone disease. N Eng J Med, 1969, 280, 193–202.

    Google Scholar 

  28. Joly, R., Chapuy, M.C., Alexandre, C.L., Meunier, P.J. Osteoporoses a haut niveau de remodelage et fonction parathyroidienne. Pathol Biol, 1980, 7, 417–424.

    Google Scholar 

  29. Delmas, P., Wehner, H.W., Mann, K., Riggs, L.B. Assessment of bone turnover in postmenopausal osteoporosis by measurement of serum bone Glaprotein. J Lab Clin Med, 1983, 102, 470–476.

    Google Scholar 

  30. Marshall, D.H., Nordion, B.E.C. The prevention of postmenopausal bone loss. Curr Med Res Opin, 1977, 4, 73–82.

    Google Scholar 

  31. Riggs, B.L., Ryan, R.J., Wahner, H.W., Jiang, N.S., Mattox, V.R. Serum concentrations of estrogens testosterone, and gonadotropins in osteoporotic and nonosteoporotic women. J Clin Endocrinol Metab, 1973, 36, 1097–1099.

    Google Scholar 

  32. Schindler, A.E., Eberg, A., Freidrick, E. Conversion of androstenodione to estrone by human fat tissue. J Clin Endocrinol Metab, 1972, 35, 627–630.

    Google Scholar 

  33. Mac Donald, P.C., Edman, C.D., Hemsell, D.C., Porter, J.C., Siiteri, P.R. Effect of obesity on conversion of plasma androstenodione to estrone in postmenopausal women with and without endometrial cancer. Am J Obstet Gynecol, 1978, 130, 448–450.

    Google Scholar 

  34. Jasani, C., Nordion, B.E.C., Smith, D.A., Swason, I. Spinal osteoporosis and the menopause. Proc R Soc med, 1965, 58, 441–444.

    Google Scholar 

  35. Katz, F.H., Kappas, A. Influence of estradiol and estriol on urinary excretion of hydroxyproline in man. J Lab Clin Med, 1968, 71, 65–7.

    Google Scholar 

  36. Teitelbaum, J.L., Rosenberg, F.M., Richardson, C.A., Avioli, L.V. Histological studies of bone from normocalcemic postmenopausal osteoporosis patients with increased circulating parathyroid hormone. J Clin Endocrinol Metab, 1976, 42, 537–543.

    Google Scholar 

  37. Fujita, T., Orimo, H., Okano, K., Yoshikawa, M., Shino, R., Inoue, T., Itami, Y. Radioimmuno-assay of serum parathyroid hormone in postmenopausal osteoporosis. Endocrinol Jpn, 1972, 19, 571–577.

    Google Scholar 

  38. Riggs, B.L., Arnaud, C.D., Jowsey, J., Goldsmith. R.S., Kelly, P.J. Parathyroid function in primary osteoporosis. J Clin Invest, 1973, 52, 181–184.

    Google Scholar 

  39. Gallagher, J.C., Riggs, B.L., Jerpak, C.M. Arnaud, C.D. The effect of age on serum immu noreactive parathyroid hormone in normal and osteoporotic women. J Lab Clin Med, 1980, 95, 373 385.

    Google Scholar 

  40. Berlyne, G.M., Ben-Ari, J., Kusmelevsky, A. Idekman, D., Galinski, M., Hirsch, R., Shainkin, R., Yagil, R., Zlotnik, M. The etiology of senile osteoporosis: Secondary hyperparathyroidism due to renal failure. Q J Med, 1975, 44, 505–513.

    Google Scholar 

  41. Roof, B.S., Piel, C.E., Hansen, J. Serum parathyroid hormone levels and serum calcium levels from birth to senescence. Mech Ageing Dev, 1976, 5, 289–304.

    Google Scholar 

  42. Wiske, P.S., Epstein, S., Bell, N.H., Queener, S.T., Edmonson, J., Johnston, C.C. Increase in immunoreactive parathyroid hormone with age. N Eng J Med, 1979, 300, 1419–1421.

    Google Scholar 

  43. Bouillon, R., Geusens, P., Dequeker, J., De Moor, P. Parathyroid function in primary osteoporosis. Clin Sci, 1979, 57, 167–171.

    Google Scholar 

  44. Stevenson, J.C., Abeyasera, G., Hillyard, C.J., et al. Regulation of calcium-regulating hormones by exogenous sex steroids in early postmenopause. Eur J Clin Invest, 1983, 13, 481–487.

    Google Scholar 

  45. Whyte, M.P., Bergfeld, B.A., Murphy, W.A., Avioli, L.V., Teitelbaum, S.L. Postmenopausal osteoporosis: a heterogenous disorder as assessed by histomorphometric analysis of iliac crest bone from untreated patients. Am J Med, 1982, 72, 193–202.

    Google Scholar 

  46. Riggs, B.L., Jowsey, J., Kelly, P.J., Arnaud, C.D. Role of hormonal factors in the pathogenesis of postmenopausal osteoporosis. Isr J Med Sci, 1976, 12, 615–619.

    Google Scholar 

  47. Cushing, H. The basophil adenomas of the pituitary body and their clinical manifestation (Pituitary Basophilism). Bull Johns Hopkins Hosp, 1932, 50, 137–195.

    Google Scholar 

  48. Krane, S.M., Goldring, S.R. Skeletal System; neuromuscular system; emotion and mentation. In: Werner SC, Ingbar SH (ed). The thyroid. New York, Harper & Rows, 1978, 727.

    Google Scholar 

  49. Manolagas, S.C., Anderson, D.C., Lidsay, R. Adrenal steroids and the development of osteoporosis in oophorectomised women. Lancet, 1979, 2, 597–600.

    Google Scholar 

  50. Aloia, J.F., Vaswani, A., Yeh, J.K., Cohn, S.H. The pathogenesis of postmenopausal osteoporosis. Calcif Tissue Int, 1982, 34 (suppl), 28S.

  51. Hahn, T.J. Corticosteroid-induced osteopenia. Arch Inter Med, 1978, 138, 882–885.

    Google Scholar 

  52. Caniggia, A., Gennari, C., Bianchi, V., Guideri, R. Intestinal absorption of47Ca in senile osteoporosis. Acta Med Scand, 1963, 173, 613–617.

    Google Scholar 

  53. Fucik, R.F., Kukreja, S.C., Hargis, G.K., Bowser, F.N., Henderson, W.J., Williams, G.A. Effect of glucocorticoids on function of te parathyroid glands in man. J Clin Endocrinol Metab, 1975, 40, 152–155.

    Google Scholar 

  54. Jowsey, J., Riggs, B.L. Bone formation in hypercortisolism. Acta Endocrinol, 1970, 63, 21–28.

    Google Scholar 

  55. Bouillon, R., De Moor, P., Parathyroid function in patients with hyper or hypothyroidism. J Clin Endocrinol Metab, 1974, 38, 999–1004.

    Google Scholar 

  56. Adams, P.H., Jowsey, J. Bone and mineral metabolism in hyperthyroidism: an experimental study. Endocrinology, 1967, 81, 735–740.

    Google Scholar 

  57. Rico, H., Cabranes, J.A., Almoguera, L., Millan, V., Olivares, C. Alteraciones oseas en los hipertiroidismos: sugerencia de un mecanismo inducido por la T3. Rev Iberam Invest Clin, 1982, 1, 91–97.

    Google Scholar 

  58. Rico, H., Cabranes, J.A., Paniagua, M.C. et al. Es la fosfodiesterasa la responsable de las alteraciones óseas en las disfunctiones tiroideas? Med Clin (Barc), 1983, 81, 702–704.

    Google Scholar 

  59. Castro, J.H., Genusth, S.M., Klein, L. Comparative response to parathyroid hormone in hyperthyroidism and hypothyroidism. J Clin Endocrinol Metab, 1975, 42, 839–848.

    Google Scholar 

  60. Green, M. Ageing and disease. Clin Endocrinol Metab, 1981, 10, 207–228.

    Google Scholar 

  61. Davidson, B.J., Riggs, B.L., Coulan, C.B., Toft, D.O. Concentration of cytosolic estrogen receptors in patients with postmenopausal osteoporosis. Am J Obstet Gynecol, 1980, 136, 430–434.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rico, H., Charro, A., Depablos, I. et al. Lack of hormonal changes in postmenopausal women of equal weight with and without osteoporosis, including relation to time of menopause. Clin Rheumatol 3, 337–343 (1984). https://doi.org/10.1007/BF02032340

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02032340

Key words

Navigation